Saudi Journal of Kidney Diseases and Transplantation

: 2014  |  Volume : 25  |  Issue : 3  |  Page : 655--656

Favorable survival rate after kidney transplantation in diabetic patients

Behzad Einollahi, Zohreh Rostami 
 Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, I.R. Iran

Correspondence Address:
Dr. Behzad Einollahi
Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran
I.R. Iran

How to cite this article:
Einollahi B, Rostami Z. Favorable survival rate after kidney transplantation in diabetic patients.Saudi J Kidney Dis Transpl 2014;25:655-656

How to cite this URL:
Einollahi B, Rostami Z. Favorable survival rate after kidney transplantation in diabetic patients. Saudi J Kidney Dis Transpl [serial online] 2014 [cited 2021 Dec 5 ];25:655-656
Available from:

Full Text

To the Editor,

We read with great interest the article by Rajaeefard et al [1] published in your esteemed journal entitled "Graft survival rate following renal transplantation in diabetic patients." This retrospective study focused its message on drawing the attention of nephrologists to whether diabetes mellitus (DM) has an adverse affect on renal allograft survival among kidney transplant patients.

Although Iran has the largest reported experience of kidney transplantation among the Middle East countries, [2] there are limited data available on DM in Iranian kidney recipients. It is of interest that the estimated 9-year graft survival rate in 103 diabetic kidney transplant patients was favorable (84.2%). We also reported the 5-year outcome of kidney transplantation in 117 patients with DM and 135 patients without DM. [3] There was no significant difference in graft survival between the two groups of recipients (log-rank, P = 0.9). We concluded that diabetic and non-diabetic kidney transplant recipients had similar short- and mid-term graft and patient survival rates. Multivariate analysis by Cox regression showed that age and gender of the recipient, donor source and DM had no adverse effect on mid-term outcome among our patients. Boucek et al reported a similar outcome in terms of 5-year patient and graft survival in diabetic and non-diabetic recipients. [4] Similar to previous reports, Rajaeefard et al [1] did not find a significant poorer patient survival in diabetic patients when compared with non-diabetic individuals. [5],[6],[7],[8]

In the past, clinicians tended to exclude diabetic patients from kidney transplantation due to the adverse effects of immunosuppressive drugs and high morbidity and mortality after surgery. Although the reported outcome of kidney transplantation is inferior for diabetic than for non-diabetic patients, [9] the survival of uremic diabetic patients who remained on chronic hemodialysis is significantly lower than diabetic transplant recipients. [10],[11] Nowadays, the number of diabetic patients is growing rapidly worldwide and kidney transplantation is generally accepted as a treatment of choice in these patients with end-stage renal disease (ESRD). In addition, it was demonstrated that the 1-year patient survival rate was similar in diabetic and non-diabetic transplant recipients, [6],[12] while others have shown that the 5-year patient survival rate was worse in diabetics compared with non-diabetic recipients. [13],[14],[15]

In summary, the study of Rajaeefard et al [1] and our study showed that diabetic patients with ESRD are not contraindicated for kidney transplantation and they carry a favorable and promising graft survival.


1Rajaeefard AR, Almasi-Hashiani A, Hassanzade J, Salahi H. Graft survival rate following renal transplantation in diabetic patients. Saudi J Kidney Dis Transpl 2012;23:707-14.
2Einollahi B, Taheri S. Renal transplantation practice in Iran and the Middle East: Report from Iran and a review of the literature. Ann Transplant 2008;13:5-14.
3Einollahi B, Heidary F, Einollahi H, Rostami Z. Favorable renal allograft and patient outcome after transplantation in patients with diabetes mellitus: A five-year single center experience. Nephrourol Mon 2011;3:291-5.
4Boucek P, Saudek F, Pokorna E, et al. Kidney transplantation in type 2 diabetic patients: A comparison with matched non-diabetic subjects. Nephrol Dial Transplant 2002;17:1678-83.
5Woo YM, Jardine AG, Clark AF, et al. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 1999;55:692-9.
6Sutherland DE, Fryd DS, Payne WD, Ascher N, Simmons RL, Najarian JS. Kidney transplantation in diabetic patients. Transplant Proc 1987;19:90-4.
7Ekstrand A, Gronhagen-Riska C, Groop L, Salmela K, Kuhlback B, Ahonen J. Results of kidney transplantation in patients with diabetic nephropathy. Transplant Proc 1987;19:1535-6.
8Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002;62:1440-6.
9Kjellstrand CM, Simmons RL, Goetz FC, et al. Renal transplantation in patients with insulin-dependent diabetes. Lancet 1973;2:4-8.
10Parfrey PS, Hutchinson TA, Harvey C, Guttmann RD. Transplantation versus dialysis in diabetic patients with renal failure. Am J Kidney Dis 1985;5:112-6.
11Rao KV, Sutherland D, Kjellstrand CM, Najarian JS, Shapiro FL. Comparative results between dialysis and transplantation in diabetic patients. Trans Am Soc Artif Intern Organs 1977;23:427-32.
12Sutherland DE, Morrow CE, Fryd DS, Ferguson R, Simmons RL, Najarian JS. Improved patient and primary renal allograft survival in uremic diabetic recipients. Transplantation 1982;34:319-25.
13Kumar S, Merchant MR, Dyer P, et al. Increased mortality due to cardiovascular disease in type 1 diabetic patients transplanted for end-stage renal failure. Diabet Med 1994;11:987-91.
14Rischen-Vos J, van der Woude FJ, Tegzess AM, et al. Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. Nephrol Dial Transplant 1992;7:433-7.
15Shaffer D, Simpson MA, Madras PN, et al. Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up. Arch Surg 1995;130:283-7.